Ticker name:SMMTSummit Therapeutics Inc.

Country: US-Sector: Healthcare, Industry: Biotechnology

Summit Therapeutics Inc. is a biopharmaceutical firm dedicated to discovering, developing, and commercializing therapeutic solutions, primarily targeting infectious diseases across the United States and Latin America. The company's clinical development pipeline is heavily concentrated on therapies for Clostridioides difficile infection (CDI). Its flagship product candidate, ridinilazole, is an orally administered small molecule antibiotic currently advancing through Phase III clinical trials as a treatment for CDI. Beyond its lead asset, Summit Therapeutics is also progressing SMT-738, designed to combat multidrug-resistant infections, notably carbapenem-resistant Enterobacteriaceae (CRE). Additionally, its DDS-04 series represents a potential therapeutic avenue for various infections caused by the Enterobacteriaceae family of bacteria. Established in 2003, the company maintains its headquarters in Cambridge, Massachusetts.

Market Cap 14B

Last close 17.72$

Key metrics

Largest 20 companies In Biotechnology

# PositionTickerCompany NameMarket CapLast PriceAction
1VRTXVERTEX PHARMACEUTICALS INC / MA131B516.34$
2REGNREGENERON PHARMACEUTICALS, INC.81B789.45$
3MRNAModerna, Inc.63B158.07$
4RVMDRevolution Medicines, Inc.42B196.94$
5ALNYALNYLAM PHARMACEUTICALS, INC.33B245.51$
6ROIVRoivant Sciences Ltd.29B39.98$
7INSMINSMED Inc27B123.98$
8INCYINCYTE CORP26B127.62$
9UTHRUNITED THERAPEUTICS Corp21B497.27$
10JAZZJazz Pharmaceuticals plc16B243.84$
11ASNDAscendis Pharma A/S16B239.04$
12NBIXNEUROCRINE BIOSCIENCES INC15B151.83$
13EXELEXELIXIS, INC.14B58.49$
14SMMTSummit Therapeutics Inc.14B17.72$
15BBIOBridgeBio Pharma, Inc.13B67.31$
16BMRNBIOMARIN PHARMACEUTICAL INC13B65.08$
17HALOHALOZYME THERAPEUTICS, INC.12B109.68$
18CORTCORCEPT THERAPEUTICS INC12B114.86$
19MDGLMADRIGAL PHARMACEUTICALS, INC.12B534.4$
20TECHBIO-TECHNE Corp11B72.41$